Related references
Note: Only part of the references are listed.Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients
Takenao Koseki et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Factors Associated With Hepatitis A Mortality During Person-to-Person Outbreaks: A Matched Case-Control Study-United States, 2016-2019
Megan G. Hofmeister et al.
HEPATOLOGY (2021)
Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990-2019
Dan-Yi Zeng et al.
JOURNAL OF HEPATOLOGY (2021)
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
Jean-Selim Driouich et al.
NATURE COMMUNICATIONS (2021)
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
Marion Migueres et al.
VIRUSES-BASEL (2021)
Favipiravir and COVID-19: A Simplified Summary
Morteza Ghasemnejad-Berenji et al.
DRUG RESEARCH (2021)
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide-Based 3-or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study
Jean van Wyk et al.
CLINICAL INFECTIOUS DISEASES (2020)
Favipiravir and Zanamivir Cleared Infection with Influenza B in a Severely Immunocompromised Child
Casper K. Lumby et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection
Tatsuo Kanda et al.
VIRUSES-BASEL (2020)
Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity
Niels Mejer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig
Thomas R. Lane et al.
ANTIVIRAL RESEARCH (2020)
RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19
Mitsuhiro Machitani et al.
CANCER SCIENCE (2020)
Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis
Kirsten Alexandra Eberhardt et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Synergistic Lethal Mutagenesis of Hepatitis C Virus
Isabel Gallego et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation Sequencing
Daniel H. Goldhill et al.
JOURNAL OF VIROLOGY (2019)
Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV
Abdo A. Elfiky et al.
LIFE SCIENCES (2019)
Respiratory syncytial virus: diagnosis, prevention and management
Rachael Barr et al.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2019)
Characterization of susceptibility variants of poliovirus grown in the presence of favipiravir
Tohru Daikoku et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2018)
UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients
Stefania Notari et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Hepatitis A Virus Genome Organization and Replication Strategy
Kevin L. McKnight et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis A
Eui-Cheol Shin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
The mechanism of resistance to favipiravir in influenza
Daniel H. Goldhill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin
Mariana Baz et al.
ANTIVIRAL THERAPY (2017)
An Unusual Protector-Protege Strategy for the Biosynthesis of Purine Nucleoside Antibiotics
Pan Wu et al.
CELL CHEMICAL BIOLOGY (2017)
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience
Tristan Delory et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
Hospitalization and mortality due to hepatitis A in Taiwan: a 15-year nationwide cohort study
C. -M. Chen et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
Ana I. de Avilla et al.
PLOS ONE (2016)
Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine
Thomas S. Y. Chan et al.
ANNALS OF HEMATOLOGY (2015)
The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity
Tatsuo Kanda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Effective Lethal Mutagenesis of Influenza Virus by Three Nucleoside Analogs
Matthew D. Pauly et al.
JOURNAL OF VIROLOGY (2015)
Natural interferon-beta treatment for patients with chronic hepatitis C in Japan
Reina Sasaki et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598
Weiwei Xue et al.
ANTIVIRAL RESEARCH (2014)
In Vivo Emergence of a Novel Mutant L159F/L320F in the NS5B Polymerase Confers Low-Level Resistance to the HCV Polymerase Inhibitors Mericitabine and Sofosbuvir
Xiao Tong et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Characterization of Susceptibility Variants of Influenza Virus Grown in the Presence of T-705
Tohru Daikoku et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
Evolution of Tertiary Structure of Viral RNA Dependent Polymerases
Jiri Cerny et al.
PLOS ONE (2014)
Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
Lisa Oestereich et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Favipiravir elicits antiviral mutagenesis during virus replication in vivo
Armando Arias et al.
ELIFE (2014)
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2013)
Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B
Satoru Hagiwara et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients
Julia Dietz et al.
JOURNAL OF VIROLOGY (2013)
Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis
Ana M. Ortega-Prieto et al.
PLOS ONE (2013)
Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
Huw Price et al.
PLOS ONE (2013)
Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan
Jun Yan et al.
HEPATOLOGY RESEARCH (2012)
Sequence Heterogeneity in NS5A of Hepatitis C Virus Genotypes 2a and 2b and Clinical Outcome of Pegylated-Interferon/Ribavirin Therapy
Ahmed El-Shamy et al.
PLOS ONE (2012)
Interleukin-29 Suppresses Hepatitis A and C Viral Internal Ribosomal Entry Site-Mediated Translation
Tatsuo Kanda et al.
VIRAL IMMUNOLOGY (2012)
Virologic and biochemical responses to clevudine in patients with chronic HBV infection- associated cirrhosis: data at week 48
J. H. Kim et al.
JOURNAL OF VIRAL HEPATITIS (2011)
The Hepatitis C Virus (HCV) NS4B RNA Binding Inhibitor Clemizole Is Highly Synergistic with HCV Protease Inhibitors
Shirit Einav et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha
Lingli Yang et al.
VIROLOGY JOURNAL (2010)
Famciclovir reduces viral mucosal shedding in HSV-Seropositive persons
Peter Leone et al.
SEXUALLY TRANSMITTED DISEASES (2007)
Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human Hepatocytes
Tatsuo Kanda et al.
JOURNAL OF VIROLOGY (2007)
The anti-yellow fever virus activity of ribavirin is independent of error-prone replication
P Leyssen et al.
MOLECULAR PHARMACOLOGY (2006)
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1
Y Benhamou et al.
JOURNAL OF HEPATOLOGY (2006)
Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications
M Vignuzzi et al.
VIRUS RESEARCH (2005)
Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon-α
Y Tanabe et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA
T Kanda et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract
R Gupta et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity
JK Pfeiffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(I)-poly(C), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons
RE Lanford et al.
JOURNAL OF VIROLOGY (2003)
Replication of a hepatitis A virus replicon detected by genetic recombination in vivo
V Gauss-Müller et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Viral dynamics and pharmacokinetics in combined interferon alfa-2b and ribavirin therapy for patients infected with hepatitis C virus of genotype 1b and high pretreatment viral load
A Tsubota et al.
INTERVIROLOGY (2002)
Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon
W Markland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
